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A MATHEMATICAL TREATMENT OF THE FLUORESCENCE
CAPILLARY-FILL DEVICE∗
MAGDA REBELO † , TERESA DIOGO ‡ , AND SEAN MCKEE §
Abstract. A mathematical model in the form of two coupled diffusion equations is provided
for a competitive chemical reaction between an antigen and a labelled antigen for antibody sites on
a cell wall; boundary conditions are such that the problem is both nonlinear and nonlocal. This is
then re-characterized first as a pair of coupled singular integro-differential equations and then as a
system of four Volterra integral equations. The latter permits a proof of existence and uniqueness
of the solution of the original problem. Small and large time asymptotic solutions are derived and,
from the first characterization, a regular perturbation solution is obtained. Numerical schemes are
briefly discussed and graphical results are presented for human immunoglobulin.
Key words. Mathematical model, capillary-fill device, antibody-antigen, Volterra equations,
existence and uniqueness, asymptotic results, regular perturbation, numerical approximation.
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1. Introduction. This paper is concerned with the development and analysis
of a mathematical model of the Fluorescence Capillary-Fill Device (FCFD) described
in detail by Badley et al.[1].
The FCFD consists of two plates of glass, separated by a narrow gap. The lower
plate is coated with an immobilized layer of specific antibody and acts like an optical
waveguide. The upper plate has an attached reagent layer of antigen (or hapten)
labelled with fluorescent dye. When a sample (usually urine or blood) is introduced,
by capillary action, into the gap between the two plates of the FCFD it dissolves
the reagent. The fluorescently labelled antigen in the reagent now competes with the
sample antigen for the limited number of antibody binding sites on the wave guide
solid face. The gap between the glass plates is chosen to be narrow so that the reaction
may be completed in a short time. The objective is to measure the antigen present
in the sample. A schematic diagram is given in Figure 1.1.
In this paper we focus on the competitive reaction between the antigen and the
fluorescent antigen for those antibody sites affixed to the lower glass plate. An exten-
sive mathematical study will be provided: it is organized as follows.
Firstly, the mathematical model is developed and nondimensionalized. The math-
ematical model consists of two coupled diffusion equations with nonlocal, nonlinear
boundary conditions. In section 3 a Laplace transform technique shows that this diffu-
sion problem may be expressed equivalently as a coupled system of integro-differential
equations. A further characterization in the form of four coupled Volterra integral
equations is developed in section 4. It is this latter characterization that provides
existence and uniqueness of the solution to the original diffusion problem. This is
demonstrated in section 5. In section 6 we return to the system of integro-differential
∗
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Fig. 1.1. Schematic diagram of the fluorescence capillary-fill device (FCFD) illustrating a
competition immunoassay for a desired antigen or hapten. (a) Cutaway view of device showing
construction and optical waveguiding principles. (b) Enlarged insert of gap in the empty device
showing immobilized antibody layer on lower plate and dissoluble reagent layer on upper plate. (c)
Enlarged inset of gap in the filled device showing competitive immunological binding of the desired
antigen or hapten and its fluorescently labelled counterpart (the conjugate) to the limited number of
antibody molecules. (Reprinted from [1] with the kind permission of the Royal Society of London.)
equations and develop a regular perturbation solution for the two complexes (i.e. an-
tibody/antigen and antibody/labelled antigen molecules). Section 7 is dedicated to
obtaining both small and large time asymptotic results for all the dependent variables.
Section 8 briefly discusses numerical methods while section 9 provides typical results
for human immunoglobulin and antigens or haptens1. The paper concludes with a
discussion on design considerations.
2. The mathematical model. A dissoluble reagent layer of antigen (or hap-
ten) labelled with a fluorescent dye is affixed to one wall of a small cell while a specific
antibody is immobilized on another (parallel) wall. The cell is then filled, through
capillary action, with a fluid which may or may not contain the (unlabelled) antigen.
The objective is to determine whether this antigen is present and, if so, in what quan-
tity. For instance, if a patient had a particular disease then (unlabelled) antigen would
be present; otherwise, it would not be. The glass plates then act as a wave guide and
a fluorescent beam is used to detect whether there is any (unlabelled) antigen (see
Badley et al. [1]).
Initially, the labelled antigen is wall-bound and it will be denoted by X(b)F . Upon
dissolving, it shall be denoted by XF . Furthermore, let X denote the unlabelled
antigen and Y the specific antibody. Both XF and X are free to diffuse in the
solution, whereas the antibody Y is insoluble and remains on the lower plate where
the antibody and the antigens react in the following way:
X + Y k1⇋k2
XY ; XF + Y
k3⇋k4
XFY.
1Haptens are low-molecular weight molecules that contain an antigenic determinant but which
are not themselves antigenic unless completed with an immunogenic carrier.
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Fig. 2.1.
Thus on the lower plate labelled (XFY ) and unlabelled (XY ) antigen-antibody
molecules are created.
On the other hand, the wall-bound antigen X(b)F is treated as an independent
species and we consider its dissolution as a further reaction
k5
X(b)F → XF .
Note that the concentration of the labelled antigen on the side wall (i.e. [X(b)F ])
is dissolved upon entry of the fluid possibly containing the unlabelled antigen; there
is no recombination, so it is reasonable to consider the reaction as one way only.
The parameters k1, k2 are the forward and backward reaction rates associated
with the unlabelled antigen X ; k3, k4 are the forward and backward reaction rates
associated with the labelled antigen XF and k5 is the forward ”reaction” rate associ-
ated with the wall-bound antigen X(b)F (i.e. the rate at which X
(b)
F dissolves). Let d
denote the plate separation distance.
We introduce the following variables:
• [X ]: concentrations (in moles/m3) of X ,
• [XF ]: concentrations (in moles/m3) of XF ,
• [X(b)F ]: concentrations (in moles/m2) of X
(b)
F at x = 0,
• [Y ]: concentrations (in moles/m2) of Y at x = d,
• [XY ]: concentrations (in moles/m2) of XY at x = d,
• [XFY ]: concentrations (in moles/m2) of XFY at x = d.
The variables [X ] and [XF ] will now depend on x and t whereas [XY ], [XFY ], [Y ]
and [X(b)F ] only depend on t.
Define the following constants
• a: initial concentration of X (moles/m3),
• aF : initial concentration of X(b)F (moles/m2),
• c: initial concentration of Y (moles/m2),
• D: denotes the diffusion coefficient associated with X(m2/s),
• DF : denotes the diffusion coefficient associated with XF (m2/s).
The plate separation distance d is small compared with the size of the cell, i.e. d≪ L
as illustrated in Figure 2.1. Thus, by defining the origin to be at some point on the
upper plate (represented by the left-hand plate in Figure 2.1) and denoting x = d to be
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the corresponding point on the lower plate (the right-hand plate), the one-dimensional
model may be written down:
∂[X ]
∂t (x, t) = D
∂2[X ]
∂x2 (x, t), x ∈ (0, d), t > 0,(2.1)
∂[XF ]
∂t (x, t) = DF
∂2[XF ]
∂x2 (x, t), x ∈ (0, d), t > 0,(2.2)
∂[X ]
∂x (x, t) = 0, x = 0, t > 0,(2.3)
DF
∂[XF ]
∂x (x, t) =
d[X(b)F ]
dt (t) = −k5[X
(b)
F ](t), x = 0, t > 0,(2.4)
D∂[X ]∂x (x, t) = −k1[X ](x, t)[Y ](t) + k2[XY ](t), x = d, t > 0,(2.5)
DF
∂[XF ]
∂x (x, t) = −k3[XF ](x, t)[Y ](t) + k4[XFY ](t), x = d, t > 0,(2.6)
[X ](x, 0) = a, x ∈ (0, d),(2.7)
[XF ](x, 0) = 0, x ∈ (0, d),(2.8)
[X(b)F ](0) = aF ,(2.9)
[Y ](0) = c,(2.10)
[XY ](0) = 0,(2.11)
[XFY ](0) = 0.(2.12)
Equations (2.5) and (2.6) result from a conservation of flux at the interface x = d,
coupled with the law of mass action for a second order chemical reaction.
One mole of X (XF ) plus one mole of Y produces one mole of XY (XFY ).
Conservation of mass then implies
∫ d
0
[X ](x, t)dx + [XY ](t) = a d, t > 0,(2.13)
and
∫ d
0
[XF ](x, t)dx + [XFY ](t) = aF (1− exp(−k5t)) , t > 0.(2.14)
Note that it is necessary to integrate over x ∈ [0, d] to determine the total number
of molecules in the bulk fluid. In a similar fashion, the number of moles of Y must
be equal to the initial number less those used up by the chemical reaction. Thus
[XY ](t) + [XFY ](t) + [Y ](t) = c, t > 0.(2.15)
Eliminating [Y ] in (2.5) and (2.6) by using (2.15) results in
D∂[X ]∂x (x, t) = −k1[X ](x, t)(c− [XY ](t) − [XFY ](t)) + k2[XY ](t), x = d,
(2.16)
DF
∂[XF ]
∂x (x, t) = −k3[XF ](x, t)(c − [XY ](t)− [XFY ](t)) + k4[XFY ](t), x = d.
(2.17)
THE FLUORESCENCE CAPILLARY-FILL DEVICE 5
2.1. Nondimensionalization. The above equations will be nondimensionalized
with respect to the plate separation distance and the labelled antigen diffusion time
scale:
x′ = x/d, t′ = (DF /d2)t.(2.18)
Furthermore, the dependent variables will be scaled as follows:
u(x′, t′) = d [X ](x, t)aF
, v(x′, t′) = d [XF ](x, t)aF
(2.19)
w1(t′) =
[XY ](t)
c , w2(t
′) =
[XFY ](t)
c .(2.20)
Dropping the primes, and after a little manipulation, the following non-dimensional
model is delivered:
∂u
∂t (x, t) = δ
∂2u
∂x2 (x, t),
∂v
∂t (x, t) =
∂2v
∂x2 (x, t), x ∈ (0, 1), t > 0,(2.21)
subject to
u(x, 0) = µ, x ∈ (0, 1),(2.22)
v(x, 0) = 0, x ∈ (0, 1),(2.23)
∂u
∂x (0, t) = 0, t > 0,(2.24)
∂v
∂x(0, t) = −λ exp(−λ t), t > 0,(2.25)
∂u
∂x (1, t) = γ1m (L1w1(t)− (1− w1(t)− w2(t))u(1, t)) , t > 0,(2.26)
∂v
∂x(1, t) = γ2m (L2w2(t)− (1− w1(t)− w2(t)) v(1, t)) , t > 0,(2.27)
together with the constraints
mw1(t) +
∫ 1
0
u(x, t)dx = µ, t > 0,(2.28)
mw2(t) +
∫ 1
0
v(x, t)dx = 1− exp(−λ t), t > 0,(2.29)
where
δ = DDF
, µ = a daF
, γi =
Ei
1 + Li
, i = 1, 2.(2.30)
The other non-dimensional constants are
m = caF
,(2.31)
L1 =
dk2
aFk1
, L2 =
dk4
aFk3
,(2.32)
E1 =
d2
D
(aF
d k1 + k2
)
, E2 =
d2
DF
(aF
d k3 + k4
)
,(2.33)
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which represent the molar ratio, the reaction time-scale ratios and the diffusion/reaction
time-scale ratios, respectively. We also define
λ = k5
d2
DF
,(2.34)
which can be regarded as the dissolution/diffusion time-scale ratio.
3. An integro-differential equation formulation. Denote the Laplace trans-
form of u (and v) with respect to time by u (and v):
u(x, s) =
∫ ∞
0
e−stu(x, t)dt,
v(x, s) =
∫ ∞
0
e−stv(x, t)dt.
Thus, taking Laplace transforms of equations (2.21) and solving the resultant ordinary
differential equations yields
u(x, s) = µs +A1(s) cosh
(√s
δ x
)
+B1(s) sinh
(√s
δ x
)
,(3.1)
v(x, s) = A2(s) cosh
(√
s x
)
+B2(s) sinh
(√
s x
)
,(3.2)
where
B1(s) = 0,
B2(s) = −
λ√s(s+ λ) ,
A1(s) =
1√ s
δ sinh
(√ s
δ
) dudx (1, s),
A2(s) =
1√s sinh (√s)
(dv
dx (1, s) +
λ
s+ λ cosh
(√
s
))
.
Note that the initial conditions (2.22) and (2.23) and (the transforms of) the boundary
conditions (2.24) and (2.25) have been employed.
Equations (3.1) and (3.2) (for x = 1) may be written as
u(1, s) = µs +
du
dx (1, s)K
(s
δ
)
,(3.3)
v(1, s) = g(s) + dvdx(1, s)K (s) ,(3.4)
where
K(s) = coth(
√s)√s = L
[
1√
πt
(
1 + 2
∞∑
n=1
exp
(
−n
2
t
))
; s
]
(3.5)
and
g(s) = λ
(s+ λ)√s sinh(√s)
= L
[
1− exp(−λt) + 2λ
∞∑
n=1
(−1)n
λ− n2π2
(
exp(−n2π2t)− exp(−λt)
)
; s
]
.(3.6)
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Invoking convolution yields
u(1, t) = µ+ δ
∫ t
0
∂u
∂x (1, τ)K(δ(t− τ))dτ, t > 0,(3.7)
v(1, t) = g(t) +
∫ t
0
∂v
∂x(1, τ)K(t− τ)dτ, t > 0.(3.8)
Differentiate equations (2.28) and (2.29) with respect to t to obtain
mdw1(t)dt +
∫ 1
0
∂u(x, t)
∂t dx = 0,(3.9)
mdw2(t)dt +
∫ 1
0
∂v(x, t)
∂t dx = λ exp(−λt).(3.10)
Using (2.21), (2.24) and (2.25) further gives
−mdw1dt (t) = δ
∂u
∂x(1, t),(3.11)
−mdw2dt (t) =
∂v
∂x(1, t).(3.12)
Combining (2.26) ( (2.27) ), (3.7) ( (3.8) ) and (3.11) ( (3.12) ) yields two coupled
integro-differential equations for w1(t), (w2(t)):
dw1(t)
dt = γ1δ
[
(1− w1(t)− w2(t))
(
µ−m
∫ t
0
dw1
dτ (τ)K(δ(t − τ))dτ
)
− L1w1(t)
]
,
(3.13)
dw2(t)
dt = γ2
[
(1− w1(t)− w2(t))
(
g(t)−m
∫ t
0
dw2
dτ (τ)K(t − τ)dτ
)
− L2w2(t)
]
,
(3.14)
subject to the initial conditions w1(0) = w2(0) = 0, with δ, µ,m and Ei, γi, i = 1, 2,
defined through (2.30)-(2.34), and
g(t) = 1− exp(−λt) + 2λ
∞∑
n=1
(−1)n
λ− n2π2
(
exp(−n2π2t)− exp(−λt)
)
,(3.15)
K(t) = 1√
πt
(
1 + 2
∞∑
n=1
exp
(
−n
2
t
))
.(3.16)
4. A further characterization. In the previous section it was shown that the
original system of diffusion equations could be characterized as a coupled system
of weakly singular integro-differential equations. The purpose of this section is to
demonstrate that there is a further characterization of the original system in the form
of a 4× 4 system of Volterra integral equations.
4.1. Preliminary results. Define the theta function
θ(x, t) = 1√
4πt
∞∑
n=−∞
exp
(
− (x+ 2n)
2
4t
)
, −∞ < x < +∞, t > 0.(4.1)
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By extending the results of [3], Jumarhon and McKee [7] proved the following:
Lemma 4.1. Consider the heat equation with nonlinear boundary conditions
ut(x, t) = uxx(x, t), 0 < x < 1, t > 0,
u(x, 0) = 1, 0 < x < 1,
ux(0, t) = 0, t > 0,
ux(1, t) =
Em
1 + L (Lw(t)− (1− w(t))u(1, t)) , t > 0,
mw(t) +
∫ 1
0
u(x, t)dx = 1.
(4.2)
The solution to (4.2) has the form
u(x, t) = 1 + 2
∫ t
0
θ(x − 1, t− τ)G(ϕ1(τ), ϕ2(τ))dτ(4.3)
if and only if (ϕ1(t), ϕ2(t)) is the unique piecewise-continuous solution of
ϕ1(t) = 1 +
∫ t
0
K(t− τ)G(ϕ1(τ), ϕ2(τ))dτ,(4.4)
ϕ2(t) = 1 +
∫ t
0
G(ϕ1(τ), ϕ2(τ))dτ,(4.5)
where K is defined by (3.16) and
G(ϕ1(τ), ϕ2(τ)) = CL − C(m− 1)ϕ1(τ) − CLϕ2(τ) − Cϕ1(τ)ϕ2(τ),(4.6)
with C = E/(1 + L). Here ϕ1(t) = u(1, t) and ϕ2(t) =
∫ 1
0
u(x, t)dx.
4.2. A system of Volterra integral equations. It is straightforward to show
that the previous result generalizes to systems of equations. Consider the system
defined by (2.21)-(2.29). This may be rewritten as follows:
ut(x, t) = Auxx(x, t), 0 < x < 1, t > 0,(4.7)
u(x, 0) = (µ, 0)T , 0 < x < 1,(4.8)
ux(0, t) = (0,−λ exp(−λt))T , t > 0,(4.9)
ux(1, t) = (γ1m (L1w1(t) − (1− w1(t)− w2(t))u(1, t)) ,
γ2m (L2w2(t)− (1− w1(t)− w2(t)) v(1, t)))T , t > 0,(4.10)
(mw1(t),mw2(t))T = (µ, 1 − exp(−λt))T −
∫ 1
0
u(x, t)dx, t > 0,(4.11)
where u(x, t) = (u(x, t), v(x, t))T and A =
[
δ 0
0 1
]
.
Let Φ1(t) =
(
Φ11(t),Φ12(t)
)T
and Φ2(t) =
(
Φ21(t),Φ22(t)
)T
be given by
Φ1(t) = (u(1, t), v(1, t))T = u(1, t),
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Φ2(t) =
(∫ 1
0
u(x, t)dx,
∫ 1
0
v(x, t)dx
)T
=
∫ 1
0
u(x, t)dx,
then from (4.11) we have
mw1(t) = µ−
∫ 1
0
u(x, t)dx = µ− Φ21(t),(4.12)
mw2(t) = 1− exp(−λt)−
∫ 1
0
v(x, t)dx = 1− exp(−λt)− Φ22(t).(4.13)
Combining (4.10) and (4.12)-(4.13) gives
ux(1, t) = γ1m (L1w1(t)− (1− w1(t)− w2(t))u(1, t))
= γ1
(
L1µ− ρ(t)Φ11(t)− (L1 +Φ11(t))Φ21(t)− Φ11(t)Φ22(t)
)
= F1(t,Φ1(t),Φ2(t)),(4.14)
vx(1, t) = γ2m (L2w2(t)− (1− w1(t)− w2(t)) v(1, t))
= γ2
(
L2 (1− exp(−λt))− ρ(t)Φ12(t)− (L2 +Φ12(t))Φ22(t)− Φ12(t)Φ21(t)
)
= F2(t,Φ1(t),Φ2(t)),(4.15)
with ρ(t) = m− µ− 1 + exp(−λt). Thus, the boundary condition (4.10) may be writ-
ten as
ux(1, t) =
(
F1(t,Φ1(t),Φ2(t)), F2(t,Φ1(t),Φ2(t))
)T
= F(t,Φ1(t),Φ2(t))
= F
(
t,u(1, t),
∫ 1
0
u(x, t)dx
)
.(4.16)
The second characterization may now be written down as a theorem.
Theorem 4.2. The solution of (4.7)-(4.11) has the form
u(x, t) = (µ, 0)T +
(
0, 2λ
∫ t
0
θ(x, t − τ) exp(−λτ)dτ
)T
+ 2
∫ t
0
AΘ(x− 1, δ(t− τ), t− τ)F(τ,Φ1(τ),Φ2(τ))dτ(4.17)
if and only if
(
Φ1, Φ2
)
is the unique piecewise-continuous solution of
Φ1(t) = (µ, g(t))T +
∫ t
0
K(t− τ)F(τ,Φ1(τ),Φ2(τ))dτ,(4.18)
Φ2(t) = (µ, 1− exp(−λt))T +
∫ t
0
AF(τ,Φ1(τ),Φ2(τ))dτ,(4.19)
with A =
[
δ 0
0 1
]
, Θ(x, y, z) =
[
θ(x, y) 0
0 θ(x, z)
]
, K(t) =
[
δK(δt) 0
0 K(t)
]
,
where the function g(t) is defined by
g(t) = 2λ
∫ t
0
θ(1, t− s) exp(−λs)ds,(4.20)
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with θ and K given by (4.1) and (3.16), respectively.
Note that g(t) may be written in the form (3.15). The system of integral equations
(4.18)-(4.19) consists of four Volterra integral equations of the second kind:



Φ11(t) = µ+ δ
∫ t
0
K(δ(t− τ))F1(τ,Φ1(τ),Φ2(τ))dτ ,
Φ12(t) = g(t) +
∫ t
0
K(t− τ)F2(τ,Φ1(τ),Φ2(τ))dτ ,
Φ21(t) = µ+ δ
∫ t
0
F1(τ,Φ1(τ),Φ2(τ))dτ ,
Φ22(t) = 1− exp(−λt) +
∫ t
0
F2(τ,Φ1(τ),Φ2(τ))dτ .
(4.21)
5. Existence and uniqueness of the solution. The model represented by
the 2 × 2 system of diffusion equations has been equivalently characterized by both
a system of integro-differential equations and a 4 × 4 system of Volterra integral
equations. It is this latter formulation that we wish to focus upon.
Existence and uniqueness of the solution of this system will imply existence and
uniqueness of the solution of the original diffusion model (and vice versa). Some
preliminary results are required.
5.1. Preliminaries. For σ > 0 and n ∈ N, define the ball
Snσ = {x ∈ Rn : ‖x‖1 ≤ σ} ,(5.1)
where x = (x1, ..., xn)T and ‖x‖1 =
n∑
i=1
|xi|.
The following lemma is a special case of the result of combining Theorem 2.3 and
Corollary 2.7 from [12] (Chapter II). For details of the argument, see Jumarhon and
McKee [7].
Lemma 5.1. Consider the system of integral equations
X(t) = U(t) +
∫ t
0
V (t, s,X(s))ds, t > 0,(5.2)
with
X(t) = (X1(t), ..., Xn(t))T ,
U(t) = (U1(t), ..., Un(t))T ,
V (t, s,X(s)) = (V1(t, s,X(s)), ..., Vn(t, s,X(s)))T ,
where U is continuous on [0,+∞) and V is a continuous function on the set
D = {(t, s, x) : 0 < s < t <∞, x ∈ Rn}.
Suppose
(i) ∀ T > 0 and ψ : [0, T ] −→ Rn continuous, V (t, s, ψ(s)) is continuous for
s ∈ (0, t) and
∥∥∥∥
∫ t
0
V (t, s, ψ(s))ds
∥∥∥∥
1
<∞ for t ∈ [0, T ];
(ii) there exists q(t, s) continuous on 0 < s < t <∞ satisfying
∫ t
0
q(t, s)ds <∞, t ∈ (0,+∞),
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and ∀ T > 0, as ǫ→ 0+,
∫ t+ǫ
t
q(t+ ǫ, s)ds→ 0, t ∈ [0, T ],
uniformly in t, such that
||V (t, s, x)− V (t, s, y)||1 ≤ q(t, s)||x − y||1,
for all σ > 0 and x, y ∈ Snσ .
Then we have
(a) there exists an α > 0 such that the system of Volterra integral equations (5.2)
has a unique continuous solution on [0, α];
(b) furthermore, if there exists B > 0, such that ||X(t)||1 is bounded by B on all
intervals [0, β] (β > 0) on which (5.2) has a unique continuous solution, then
(5.2) has a unique continuous solution on [0,∞).
5.2. Existence and uniqueness. It is convenient at this stage to introduce the
following notation:
F1(t) = F1(t,Φ1(t),Φ2(t)), F2(t) = F2(t,Φ1(t),Φ2(t)),(5.3)
x1(t) = Φ11(t), x2(t) = Φ12(t), x3(t) = Φ21(t), x4(t) = Φ22(t).(5.4)
For the existence and uniqueness result we shall restrict our attention to the case
k1 = k3, k2 = k4 andD = DF (so that, δ = 1, L1 = L2(= L, say), E1 = E2(= E, say)
and γ1 = γ2(= γ, say)). These are not unreasonable assumptions since in many
cases the antigen and labelled antigen will be (essentially) the same molecule and
consequently will have the same diffusion coefficients and reaction rates.
In order to prove that the system (4.21) has a unique continuous solution on
[0,∞[ we first need to prove the following lemma.
Lemma 5.2. Let us consider the initial value problem (2.21)-(2.29) with the above
assumptions. Suppose there exists a T0 > 0 such that (4.21) has a unique continuous
solution,
(
Φ1(t),Φ2(t)
)
, on [0, T0], then
F (t) = F1(t) + F2(t) < 0, t ∈ [0, T0].(5.5)
Proof. Using (4.14) and (4.15) allows us to rewrite F1 and F2 as follows
F1(t) = γ (Lµ− (ρ(t) + x3(t) + x4(t))x1(t)− Lx3(t)) ,(5.6)
F2(t) = γ (L (1− exp(−λt)) − (ρ(t) + x3(t) + x4(t)) x2(t)− Lx4(t)) ,(5.7)
where ρ(t) = m− µ− 1 + exp(−λt).
From (5.6) and (5.7) we have
F (t) = γ (L (µ+ 1− exp(−λt))− (x1(t) + x2(t)) (ρ(t) + x3(t) + x4(t))
− L(x3(t) + x4(t))) .(5.8)
Defining
ψ1(t) = x1(t) + x2(t), t > 0,(5.9)
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and
ψ2(t) = x3(t) + x4(t) + exp(−λt), t > 0,(5.10)
we can rewrite F as
F (t) = γ (L(µ+ 1)− ψ1(t)(m− µ− 1 + ψ2(t))− Lψ2(t)) .
We shall now prove that F (t) < 0, ∀t ∈ [0, T0].
Suppose that there exists t1 ∈ (0, T0] such that F (t1) ≥ 0.
Now
F (0) = γ (L(µ+ 1)− ψ1(0)(m− µ− 1 + ψ2(0))− Lψ2(0)) .
From (5.9) and (5.10)
ψ1(0) = µ and ψ2(0) = µ+ 1,
so that
F (0) = −γ mµ < 0,
provided a > 0, that is, in the case of some (unlabelled) antigen present. We note that
in the case a = 0 the problem reduces to the trivial case of a single diffusion equation,
essentially studied by Jumarhon et al. [7]. We have that F (t) is a continuous function
and, since t1 6= 0, there exists a t2 ∈ (0, t1] such that
F (t) < 0, t ∈ [0, t2), and F (t2) = 0.(5.11)
The functions x1(t), x2(t), x3(t) and x4(t) are analytic on (0, T0]; thus F (t) is an
analytic function on (0, t1] and we have
F ′(t2) = lim
t→t−2
F (t)− F (t2)
t− t2
≥ 0.(5.12)
On the other hand,
F ′(t2) = −γ (ψ′1(t2)(m− µ− 1 + ψ2(t2)) + ψ1(t2)ψ′2(t2) + Lψ′2(t2)) .(5.13)
Observe that
ψ′2(t2) = x′3(t2) + x′4(t2)− λ exp(−λ t2)
= F1(t2) + F2(t2) (from (4.21))
= F (t2) = 0.(5.14)
Thus
F ′(t2) = −γψ′1(t2) (m− µ− 1 + ψ2(t2)) .(5.15)
We shall now demonstrate that
ψ′1(t2) > 0(5.16)
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and
m− µ− 1 + ψ2(t2) > 0.(5.17)
From (5.4) and (4.21) the function ψ1 satisfies
ψ1(t) = µ+ g(t) +
∫ t
0
K(t− s) (F1(s) + F2(s)) ds = µ+ g(t) +
∫ t
0
K(t− s)F (s)ds,
where g(t) is defined by g(t) = 2λ
∫ t
0
θ(1, t− s) exp(−λs)ds (see (4.20)). Using the
fact that F1(t) + F2(t) < 0, ∀t ∈ [0, t2), F (t2) = 0, K ′(t) < 0 for t > 0 (see [9]) and
following the argument provided in [7], we have
d
dt
∫ t
0
K(t− s)F (s)ds |t=t2> 0.(5.18)
We must show that g′(t2) > 0. First we note that by convolution we can rewrite g(t)
as follows
g(t) = 2λ
∫ t
0
θ(1, t− s) exp(−λs)ds = 2λ
∫ t
0
θ(1, s) exp(−λ(t− s))ds.
Then, on differentiating the second form gives
g′(t) = 2λ
(
θ(1, t)− λ
∫ t
0
exp(−λ(t− s))θ(1, s)ds
)
,(5.19)
which exists and is well-defined for t > 0.
Now differentiate the first form
g′(t) = 2λ
(
lim
t→0+
θ(1, t) +
∫ t
0
∂
∂tθ(1, t− s) exp(−λs)ds
)
.(5.20)
Define
g′ε(t) = 2λ
(
θ(1, ε) +
∫ t
0
∂
∂tθ(1, t− s) exp(−λs)ds
)
.
We observe that
∂
∂tθ(1, t) > 0, t > 0.
This follows since θ(x, t) is the solution of the heat equation with initial condition
equal to a sum of delta functions; it is then automatically increasing in t (other than
at where the singularities of the delta functions were).
Furthermore, for any ε > 0 we have θ(1, ε) > 0 implying g′ε(t) > 0. We may
construct a positive sequence g′ε(t) as close as we like to g′(t) (since its existence has
already been demonstrated) implying that g′(t) is itself positive and, in particular,
g′(t2) > 0.
In order to conclude that F ′(t2) < 0 it remains to prove that
ψ2(t2) +m− µ− 1 > 0.(5.21)
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We shall prove this by contradiction. Supposing that it is not true, assume that
ψ2(t2) ≤ µ+ 1−m.(5.22)
Since ψ2(0) = µ+ 1 > 0, ψ2(t2) ≤ µ+ 1−m < µ+ 1 and ψ2(t) is continuous, there
exists a t3 ∈ (0, t2] such that
ψ2(t3) = µ+ 1−m.(5.23)
Therefore
F (t3) = γ (L(µ+ 1)− ψ1(t3)(m− µ− 1 + ψ2(t3)) − Lψ2(t3))
= γ mL > 0.
This contradicts the hypothesis that F (t) < 0, t ∈ [0, t2]. Consequently, we must
have ψ2(t2) +m− µ− 1 > 0.
We have therefore demonstrated that (5.16) and (5.17) both hold which implies
that F ′(t2) < 0; however, this contradicts (5.12) and so F (t) = F1(t) + F2(t) < 0, for
t ∈ [0, T0].
We are now in a position to prove that the system of Volterra integral equations
(4.21), with k1 = k3, k2 = k4 and D = DF , has a unique continuous solution on
[0,∞) and, consequently, the system of partial differential equations (2.21)-(2.29) has
a unique continuous solution u = (u(x, t), v(x, t)).
Theorem 5.3. Let us consider the initial value problem (2.21)-(2.29) with
k1 = k3, k2 = k4 and D = DF . Then the equivalent system of Volterra integral
equations (4.21) has a unique continuous solution
(
Φ11(t), Φ12(t), Φ21(t), Φ22(t)
)
on
[0,∞) under the assumption, on chemical grounds, that this vector is non-negative.
Proof. It is observed that the system (4.21) is of the form (5.2) with
U(t) = (µ, g(t), µ, 1− exp(−λt))T ,(5.24)
X(t) =
(
Φ11(t), Φ12(t), Φ21(t), Φ22(t)
)T
and
V (t, s,X(s)) =
(
K(t− s)F1(s,Φ1(s),Φ2(s)), K(t− s)F2(s,Φ1(s),Φ2(s)),
F1(Φ1(s),Φ2(s)), F2(Φ1(s),Φ2(s))
)T ,(5.25)
where K(t) is given by (3.16).
It can be proved that (4.21) satisfies conditions (i), (ii) of Lemma 5.1 using the
same arguments as in [7]. Thus, from Lemma 5.1 there exists T0 > 0 such that (4.21)
has a unique continuous (local) solution on [0, T0], and so the proof of part (a) of
Lemma 5.1 is complete.
It shall now be proved that a unique continuous (global) solution(
Φ11(t), Φ12(t), Φ21(t), Φ22(t)
)
exists on [0,∞). Lemma 5.2 has demonstrated that
F1(t) + F2(t) < 0, t ∈ [0, T0], T0 > 0.
Therefore, from (5.4), (4.21) and (5.5) we have
ψ1(t) = x1(t) + x2(t)
= µ+ g(t) +
∫ t
0
K(t− s)(F1(s) + F2(s))ds < µ+ g(t).
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Since θ(1, t) is a bounded solution of the heat equation with homogeneous Neumann
conditions, boundedness of g is then immediate, then there exists a M ∈ R such that
for g(t) < M
ψ1(t) < µ+M, ∀t ∈ [0, T0].
On the other hand,
ψ2(t) = x3(t) + x4(t) + exp(−λt)
= µ+ 1 +
∫ t
0
(F1(s) + F2(s))ds < µ+ 1, ∀t ∈ [0, T0].(5.26)
We have now shown that
x1(t) + x2(t) < µ+M(5.27)
and
x3(t) + x4(t) < µ+ 1,(5.28)
for all t ∈ [0, T0]. Under the assumption that xi(t) ≥ 0, i = 1, ..., 4, this allows us to
deduce that x1(t), x2(t), x3(t) and x4(t) are all individually bounded. Invoking part
(b) of Lemma 5.1 then shows that (4.21) has a unique (global) continuous solution on
[0,∞).
Having established that the solution of the original diffusion model exists and is
unique through its equivalent integral equation characterization, we now feel confi-
dent to seek out quasi-analytic results, such as perturbation solutions and asymptotic
results and to explore numerical methods. The next three sections will deal with these
issues.
6. A regular perturbation solution. In section 2 an integro-differential sys-
tem was developed as an equivalent characterization of the original model:
dw1
dt (t) = γ1δ
[
(1− w1(t)− w2(t))
(
µ−m
∫ t
0
dw1
dτ (τ)K(δ(t − τ))dτ
)
− L1w1(t)
]
,
(6.1)
dw2
dt (t) = γ2
[
(1− w1(t)− w2(t))
(
g(t)−m
∫ t
0
dw2
dτ (τ)K(t − τ)dτ
)
− L2w2(t)
]
,
(6.2)
subject to w1(0) = w2(0) = 0, with the constants δ, µ, m and Ei, γi, i = 1, 2, de-
fined through (2.30)-(2.34), and the functions g and K given by (3.15) and (3.16),
respectively.
If m is small we may seek a regular perturbation solution in the form
wi(t) = w(0)i (t) +mw
(1)
i (t) +O(m2), i = 1, 2.(6.3)
Equating terms of O(m0), i = 1, 2, yields the differential equations
dw(0)1
dt (t) = γ1δ
(
(1− w(0)1 (t)− w
(0)
2 (t))µ− L1w
(0)
1 (t)
)
,(6.4)
dw(0)2
dt (t) = γ2
(
(1− w(0)1 (t)− w
(0)
2 (t))g(t)− L2w
(0)
2 (t)
)
.(6.5)
16 M. REBELO, T. DIOGO AND S. MCKEE
Initial conditions are
w(0)1 (0) = 0, w
(0)
2 (0) = 0.(6.6)
Equations (6.4) and (6.5) admit the solution
(
w(0)1 (t), w
(0)
2 (t)
)T
=
∫ t
0
exp
(∫ s
0
A(τ)dτ −
∫ t
0
A(s)ds
)
f(s)ds,(6.7)
where f(t) = (γ1δµ, γ2 g(t))T and A(t) =
[
γ1δ(µ+ L1) γ1δµ
γ2g(t) γ2 (g(t) + L2)
]
.
Similarly, we can obtain expressions for w(1)1 (t) and w
(1)
2 (t) (and, in principle,
higher order approximations). However, these are rather unwieldy involving a single
integral (or, in the case of higher order approximations, multiple integrals) and for
this reason we do not write them down here.
For the leading order approximation (6.4) and (6.5) one would expect it to only
be valid for m ≪ 1. However, it would appear, perhaps surprisingly, that this is not
necessarily the case. In section 8 equations (6.4) and (6.5) are solved numerically
(using an Euler-type method with a small step size) for m ≃ 192; the results, see
Figure 9.7, display a reasonable approximation to the full (numerical) solution of
(6.1) and (6.2).
7. Asymptotic results for limiting values of t. This section will be involved
with obtaining small and large t asymptotic results for the solution of the system of
integro-differential equations (6.1) and (6.2).
7.1. Asymptotic solution for small t. Since w1(0) = w2(0) = 0 and w1(t),
w2(t) are continuous for t > 0, then we have wi(t) → 0, i = 1, 2 when t→ 0+.
On the other hand, it is easily proven that for t ≤ min
{
1
ln(2)
, 1δ ln(2)
}
we have
0 ≤
∞∑
n=1
exp
(
−n
2
δt
)
<
∞∑
n=1
exp
(
− nδt
)
=
exp(−1/δt)
1− exp(−1/δt) ≤ 2 exp
(
− 1δt
)
(7.1)
and similarly
0 ≤
∞∑
n=1
exp
(
−n
2
t
)
< 2 exp
(
−1t
)
.(7.2)
This allows us to conclude that
∞∑
n=1
exp
(
−n
2
t
)
→ 0 and
∞∑
n=1
exp
(
−n
2
δt
)
→ 0 expo-
nentially when t → 0+. Hence, for small t we obtain for the kernel function K (see
(3.16))
K(t) = 1√
πt
(
1 + 2
∞∑
n=1
exp
(
−n
2
t
))
≃ 1√
πt
and
K(δt) = 1√
πδt
(
1 + 2
∞∑
n=1
exp
(
−n
2
δt
))
≃ 1√
πδt
.
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Thus, as t→ 0+ equations (6.1) and (6.2) become
dw1
dt (t) = γ1δ
(
µ− m√
π δ
∫ t
0
1√
t− τ
dw1
dτ (τ)dτ
)
,(7.3)
dw2
dt (t) = γ2
(
g(t)− m√π
∫ t
0
1√
t− τ
dw2
dτ (τ)dτ
)
.(7.4)
The unique continuous solution of (7.3) can be found in explicit form and is given
by
dw1
dt (t) = γ1δµ E1/2
(
−mγ1
√
δ
πΓ(1/2)t
1/2
)
,(7.5)
where Eβ(z) is the Mittag-Leffler function defined by
Eβ(z) =
∞∑
n=0
zn
Γ(nβ + 1) , ∀ β > 0.
Thus, from (7.5) we have
dw1
dt (t) = γ1δµ−
2µγ21mδ3/2√π t
1/2 +O(t).(7.6)
Consequently, since w1(0) = 0 we have for small t
w1(t) = γ1δµt−
4µγ21mδ3/2
3
√π t
3/2 +O(t2).(7.7)
Let us analyze the solution of the Volterra integral equation (7.4). Recall that
g(t) =
∫ t
0
exp(−λ(t− s))√
4πs
+∞∑
n=−∞
exp
(
− (2n+ 1)
2
4s
)
ds.
By a similar argument to (7.1) we observe that
+∞∑
n=−∞
exp
(
− (2n+ 1)
2
4s
)
< 4 exp
(
− 1
4s
)
,
then
g(t) < 4
∫ t
0
exp(−λ(t− s))√s exp
(
− 1
4s
)
ds = 2 exp(−λt)√π
∫ t
0
exp
(
λs− 14s
)
√s ds.
We note that exp(λs− 1/4s) is an increasing function which tends to zero as s→ 0+.
Thus exp(λs− 1/4s) is bounded for s ∈ [0, t] (with t≪ 1).
By the second mean value theorem for integrals
g(t) < 2 exp(−λt)√π exp
(
λt∗ − 1
4t∗
)∫ t
0
1√sds, t
∗ ∈ (0, t)
=
4√π exp
(
λt∗ − 1
4t∗
)(
t1/2 − λt3/2 +O(t5/2)
)
.(7.8)
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We also note that g(0) = 0 since
lim
t→0+
g(t) = lim
s→∞
sg(s) = lim
s→∞
λ√s
(s+ λ) sinh(√s) = 0.
Thus from (7.8) we can assume that g(t) takes the form
g(t) = b1t1/2 + b2t3/2 +O(t5/2) for t≪ 1,(7.9)
for some bi = bi(λ), i = 1, 2, ... .
On the other hand, the unique continuous solution of the weakly singular integral
equation (7.4) can be written as (see [2])
dw2
dt (t) = γ2 g(t) +
∫ t
0
R1/2(t, s)g(s)ds,(7.10)
where R1/2(t, s) is the resolvent kernel associated with the kernel −
mγ2√π (t − s)
−1/2,
defined by
R1/2(t, s) = (t− s)−1/2
∞∑
n=1
(
−mγ2√π Γ(1/2)
)n
Γ (n/2) (t− s)
(n−1)
2
= −mγ2√π (t− s)
−1/2 +m2γ22 −
2√πm
3γ32(t− s)1/2 + ... .
Thus, from (7.9) and (7.10) it follows that the solution of (7.4) is given by
dw2
dt (t) = b1γ2t
1/2 −
√π
2
b1mγ2t+
(
b2γ2 +
2
3
b1m2γ22
)
t3/2 +O(t2).(7.11)
Therefore, since w2(0) = 0 we have for small t
w2(t) =
2
3
b1γ2 t3/2 −
√π
4
b1mγ2t2 +O(t5/2).(7.12)
We see that w1(t) and w2(t) possess discontinuous second derivatives at t = 0.
Equation (3.7) with (3.11) gives
u(1, t) = µ−m
∫ t
0
dw1
dτ (τ)K(δ(t − τ))dτ.(7.13)
Similarly, equation (3.8) with (3.12) gives
v(1, t) = g(t)−m
∫ t
0
dw2
dτ (τ)K(t− τ)dτ.(7.14)
Combining these with (7.6) and (7.11), respectively, leads to
u(1, t) = µ− 2mγ1µ
√
δ√π t
1/2 + γ21m2δµ t+O(t3/2)(7.15)
and
v(1, t) = b1t1/2 −
√π
2
b1mγ2 t+
(
b2 +
2
3
b1m2γ2
)
t3/2 +O(t2).(7.16)
Note that u(1, t) and v(1, t) have discontinuous first derivatives at t = 0.
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7.2. Asymptotic solution for large t. On physical grounds we argue that as
t→∞ equilibrium results, that is, the concentrations of the antigens, [X ], [XF ], and
the complexes, [XY ], [XFY ], do not change.
This fact implies that there exist z∗1 , z∗2 , z∗3 and z∗4 such that
lim
t→∞
w1(t) = z∗1 and limt→∞w2(t) = z
∗
2 ,(7.17)
lim
t→∞
u(1, t) = z∗3 and limt→∞ v(1, t) = z
∗
4 .(7.18)
Observe that when equilibrium is achieved we have
lim
t→∞
u(x, t) = lim
t→∞
u(1, t)
and
lim
t→∞
v(x, t) = lim
t→∞
v(1, t),
which implies
lim
t→∞
∫ 1
0
u(x, t)dx = lim
t→∞
u(1, t) = z∗3 and limt→∞
∫ 1
0
v(x, t)dx = lim
t→∞
v(1, t) = z∗4 .
(7.19)
From (7.17) it follows that there exists a t∗ such that for all t ≥ t∗ we have
w1(t) = z∗1 and w2(t) = z∗2 .
Using the above equalities in (3.11) and (3.12) we obtain
lim
t→∞
∂u
∂x(1, t) = 0 and limt→∞
∂v
∂x(1, t) = 0,
thus from (2.26) and (2.27) we have
γ1m (L1z∗1 − (1− z∗1 − z∗2) z∗3) = 0,(7.20)
γ2m (L2z∗2 − (1− z∗1 − z∗2) z∗4) = 0.(7.21)
On the other hand, using (7.19), as t→∞ equations (2.28) and (2.29) become
mz∗1 + z∗3 = µ,(7.22)
mz∗2 + z∗4 = 1.(7.23)
Therefore, from (7.20), (7.21), (7.22) and (7.23) (z∗1 , z∗2) is a solution of the
nonlinear system of equations
{
L1z∗1 − (1 − z∗1 − z∗2) (µ−mz∗1) = 0,
L2z∗2 − (1 − z∗1 − z∗2) (1−mz∗2) = 0.
(7.24)
The values z∗1 , z∗2 , z∗3 , z∗4 are related to the dimensional concentrations [X ], [XF ], [XY ], [XFY ]
as follows
z∗1 =
[XY ](∞)
c , z
∗
2 =
[XFY ](∞)
c , z
∗
3 =
d [X ](d,∞)
aF
, z∗4 =
d [XF ](d,∞)
aF
.
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Thus, on chemical grounds, z∗1 , z∗2 , z∗3 , z∗4 must be positive. On the other hand, from
(7.22) and (7.23) and the fact that z∗3 ≥ 0 and z∗4 ≥ 0 we obtain z∗1 ≤
µ
m =
a d
c and
z∗2 ≤
1
m =
aF
c , respectively, so that (z
∗
1 , z∗2) ∈ D = [0,
µ
m ]× [0,
1
m ].
In order to obtain numerical approximations to z∗1 and z∗2 we can apply Newton’s
method to the system (7.24) with an appropriate initial approximation X(0) ∈ D.
We first rewrite the nonlinear system (7.24) as G(x, y) = 0, with
G(x, y) = (L1x− (1 − x− y) (µ−mx), L2y − (1− x− y) (1−my)) .
Then the Newton iterates are defined by
X(k+1) = X(k) −
(
G′(X(k))
)−1
G(X(k)), k = 0, 1, . . . ,(7.25)
where G′ (x, y) denotes the Jacobian matrix associated with G, given by
G′ (x, y) =
[
L1 + µ+m− 2mx−my µ−mx
1−my L2 + 1 +m− 2my −mx
]
.
In this case, we observe that
‖G′(x1, x2)−G′(y1, y2)‖1 ≤ 2m‖(x1, x2)− (y1, y2)‖1, ∀(x1, x2), (y1, y2) ∈ D.
If the initial guess X(0) is such that
∥∥∥∥
(
G′(X(0))
)−1∥∥∥∥
1
≤ β and
∥∥∥∥
(
G′(X(0))
)−1
G(X(0))
∥∥∥∥ ≤ η,
with mβ η ≤ 1/4, then we may employ the Newton-Kantorovich Theorem ([13]) to
conclude that the Newton iterates (7.25) are well-defined and converge to a solution
(z∗1 , z∗2) of G(X) = 0 which is unique in S(X(0), κ) ∩D, where
S(X(0), κ) =
{
(x, y) ∈ R2 : ‖(x, y)−X(0)‖1 ≤ (2mβ)−1
(
1 + (1− 4mβη)1/2
)
= κ
}
.
Moreover, the error estimate ‖(z∗1 , z∗2) −X(k)‖1 ≤
(4mβ η)2k
β m 2k+1 , k = 0, 1, ..., holds. In
section 9 a practical example is considered.
8. Numerical methods.
We shall restrict our considerations to numerical schemes for solving the two
systems of Volterra integral equations (4.21) and integro-differential equations(3.13)-
(3.14), as these are relatively more efficient to solve than the original system of partial
differential equations.
Asymptotic expansions for small t have already revealed singularities at t = 0
which, in practice, tend to lead to loss of accuracy in the neighborhood of the origin,
but this effect is diminished as t increases. There are a number of ways of avoiding
this, but one of the most effective is to subtract out the singularity using as many
terms in the asymptotic expansion as are necessary to maintain the accuracy of the
chosen method. (Other approaches include (a) a refinement of the mesh spacing in
the neighborhood of t = 0 and (b) a change of the independent variable in order to
eliminate the non-integer terms in the asymptotic expansion).
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In this section we shall not discuss these in any detail and simply refer the reader
to [4], [5], [8] and [10]. Rather we shall write down numerical methods of product
integration type for (3.13)-(3.14) and (4.21). Convergence of these methods has been
demonstrated elsewhere and will not be included here. In the next two subsections
we briefly describe the numerical methods we shall employ to obtain simulations of
the concentrations of the antibody, antigens and their complexes.
8.1. Numerical methods for (3.13)-(3.14). Impose on the interval I = [0, T ]
the uniform grid Ih = {ti = ih, 0 ≤ i ≤ N}, with stepsize h = T/N . On each subin-
terval [tj , tj+1], j = 0, 1, ..., N − 1, approximate w1(t) and w2(t) by their respective
linear Lagrange polynomials
1
h ((t− tj)w1(tj+1)− (t− tj+1)w1(tj)) ,(8.1)
1
h ((t− tj)w2(tj+1)− (t− tj+1)w2(tj)) .(8.2)
Then, using the approximation
∫ tj+1
tj
exp
(
− n
2
(ti − s)
)
1
(ti − s)1/2
ds ≈ exp
(
− n
2
(ti − tj)
)∫ tj+1
tj
1
(ti − s)1/2
ds,
j = 0, 1, ..., i− 1,(8.3)
leads to the scheme in the unknowns (wi1, wi2), i = 1, 2, ..., N ,



w01 = 0, w02 = 0,
wi1 − wi−11
h = γ1 δ

−L1wi1 + (1 − wi1 − wi2)

µ−m
i−1∑
j=0
Wi−j(δ)
wj+11 − wj1
h



,
wi2 − wi−12
h = γ2

−L2wi2 + (1− wi1 − wi2)

g˜(ti)−m
i−1∑
j=0
Wi−j(1)
wj+12 − wj2
h



,
(8.4)
where wik ≈ wk(ti), k = 1, 2, i = 0, 1, ..., N, with the quadrature weights given by
Wi−j(δ) =
(
1 + 2
l∑
n=1
exp
(
− n
2
δ(ti − tj)
))∫ tj+1
tj
1√
δπ(ti − s)
ds,(8.5)
and g˜(ti) is an approximation of g(t) at t = ti, obtained by the product Euler method
applied to (4.20), defined as follows
g(0) = g˜(0) = 0
g(ti) = 2λ
∫ ti
0
θ(1, ti − s) exp(−λs)ds = 2λ
i−1∑
j=0
∫ tj+1
tj
θ(1, ti − s) exp(−λs)ds
=
λ√π
i−1∑
j=0
∫ tj+1
tj
(
∞∑
n=−∞
exp
(
− (2n+ 1)
2
4(ti − s)
)
1√ti − s
)
exp(−λs)ds
≃ λ√π
i−1∑
j=0
exp(−λtj)
l∑
n=−l
exp
(
− (2n+ 1)
2
4(ti − tj)
)∫ tj+1
tj
1√ti − s
ds
= g˜(ti), i = 1, 2, ..., N.(8.6)
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We note that the scheme (8.4) requires the solution of a nonlinear system at each
step since the right-hand sides of the second and third equations of (8.4) involve a
term in (wi1)2 and (wi2)2, respectively. This can be avoided, without loss of accuracy,
if the expression (1−wi1 −wi2) is replaced by (1−wi−11 −wi−12 ). Thus (8.4) becomes



w01 = 0, w
0
2 = 0,
wi1 − w
i−1
1
h
= γ1δ

−L1wi1 + µ(1 − wi1 − wi2)−m(1 −wi−11 − w
i−1
2 )
i−1∑
j=0
Wi−j(δ)
wj+11 −w
j
1
h

,
wi2 − w
i−1
2
h
= γ2

−L2wi2 + g˜(ti)(1− wi1 − wi2)−m(1 − wi−11 −w
i−1
2 )
i−1∑
j=0
Wi−j(1)
wj+12 −w
j
2
h

.
(8.7)
Both algorithms (8.4) and (8.7) yield order one approximations.
Note in (8.6) and (8.5) the summation has been truncated at the lth term. In
order to choose the appropriate l we use the following result from [10]:
Lemma 8.1. Let l be an integer and define
θl(x, t) =
1√
4πt
l∑
n=−l
exp
(
− (x+ 2n)
2
4t
)
, −∞ ≤ x ≤ ∞, t > 0,(8.8)
then for 0 ≤ x ≤ 1 and t > 0 we have
|θ(x, t) − θl(x, t)| ≤
1
2
(
1− φ
(
(l − 1)
√
2/t
))
,(8.9)
where
φ(z) =
√
2
π
∫ z
0
exp
(
−x
2
2
)
dx
is the normal distribution function.
Given T > 0, ǫ > 0, l is chosen such that
|K(t)−Kl(t)| = 2 |θ(0, t)− θl(0, t)| < ǫ(8.10)
and
|θ(1, t)− θl(1, t)| < ǫ.(8.11)
From Lemma 8.1 we conclude that (8.10) and (8.11) are satisfied if l is chosen such
that
φ
(
(2/T )1/2l
)
> 1− ǫ.
By choosing ǫ commensurate with the accuracy of the numerical method allows us to
select the desired l such that no accuracy is lost while no unnecessary extra compu-
tation is carried out.
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8.2. Numerical methods for (4.21). From equations (2.28) and (2.29) we
have
mw1(ti) = µ−
∫ 1
0
u(x, ti)dx = µ− Φ21(ti),(8.12)
mw2(ti) = 1− exp(−λti)−
∫ 1
0
v(x, ti)dx = 1− exp(−λti)− Φ22(ti).(8.13)
Thus the numerical schemes (8.4) or (8.7) may be employed to calculate w1(t) and
w2(t) approximately and hence Φ21(t) and Φ22(t). Product integration discretization
of the first two equations of (4.21) gives the explicit Euler scheme
(
Φ11
)
i = µ+ δ
i−1∑
j=0
Wi−j(δ)F1
(
tj ,
(
Φ1
)
j ,
(
Φ2
)
j
)
,(8.14)
(
Φ12
)
i = g˜(ti) +
i−1∑
j=0
Wi−j(1)F2
(
tj ,
(
Φ1
)
j ,
(
Φ2
)
j
)
,(8.15)
where
(
Φ11
)
i ≃ Φ
1
1(ti),
(
Φ12
)
i ≃ Φ
1
2(ti) and g˜(ti), defined by (8.6), is an approximation
of the function g(t) at t = ti.
9. Numerical results.
This work was originally motivated by the paper of Badley et al. [1] and their
work concentrated on the human immunoglobulin G (hIgG); consequently most of the
calculations in this section will be made with reference to hIgG. There are two time-
scales in this process: the diffusion time-scale and the reaction time-scale. These are,
respectively, td = d2/D and tr = (k1a+ k2)−1 and essentially represent the time to
completion. Here, as before, a represents the initial amount of antigen, D the diffusion
coefficient associated with the antigen, d the gap width and k1, k2 the forward and
backward reaction rates associated with the unlabelled antigen X .
The molecular weight of hIgG is 105, D ≃ 10−11m2s−1, k1 ≃ 105(moles)−1s−1
and k2 ≃ 10−4s−1. (These rate constants, taken from Badley et al. [1], are actually
those measured for solution conditions and will not necessarily be representative of
surface-bound material.) This means that if d = 10−3m, diffusion will dominate for
all (realistic) sample concentrations, and the time equilibrium will be reached in 105s
(d2/D ∼ 10−6/10−11). A typical FCFD gap of 10−5m (0.1mm) provides a diffusion
time-scale of 103s (i.e. completion is reached in 17 minutes) and this means that
the reaction effects will only become significant for sample concentrations less than
10−8moles m−3. For narrower gaps possible with the FCFD (for example d = 10−6m)
reaction rates can only dominate for very low initial sample concentrations.
For species of low molecular weight (ca 300), such as haptens, diffusion is faster
(D ≃ 10−10m2s−1) and reaction rates substantially different (k1 = 108(moles)−1s−1,
k2 = 10−1s−1): diffusion will dominate unless the gap is extremely narrow and the
initial concentration very low.
A typical example requires 1.67×10−6moles m−3 of antigen and 33×10−5moles m−2
of antibody initially to cause saturation.
The gap width will lie in the range d ∈ [10−6, 10−3]m. In the numerical computa-
tions the data from Tables 9.1 and 9.2 has been used and we have taken d = 10−5m
for Data 1 and d = 10−4m for Data 2.
In section 7.2 it is shown that in order to obtain the limit values z∗1 , z∗2 , z∗3 , z∗4 ,
defined by (7.17)-(7.17), first the values z∗1 , z∗2 are sought by solving the nonlinear
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Table 9.1
Data used in numerical approximations.
Parameters Data 1 Data 2
Proteins (molecular weight ≃ 105) Haptens (molecular weight ≃ 300)
D 10−11m2s−1 10−11m2s−1
k1 105(moles)−1s−1 105(moles)−1s−1
k2 10−4s−1 10−4s−1
a 1.67× 10−6 moles m−3 0.83 moles m−3
DF 10−11m2s−12 10−10m2s−1
k3 105(moles)−1s−1 108(moles)−1s−1
k4 10−4s−1 10−1s−1
aF 1.67× 10−8 moles m−2 0.83 × 10−8 moles m−2
c 33× 10−5 moles m−2 1.6× 10−6 moles m−2
k5 104 s−1 104 s−1
Table 9.2
Corresponding nondimensional numbers.
Parameters Data 1 Data 2
m 19760.5 192.771
µ 0.001 10000
L1 5.988× 10−7 1.205 × 10−5
L2 5.988× 10−7 1.205 × 10−5
E1 1670 8.3× 103
E2 1670 8.3× 105
δ 1 0.1
λ 105 106
system (7.24) and then equations (7.22) and (7.23) are used to give z∗3 , z∗4 . Here we
consider the application of Newton’s method to (7.24) with X(0) = (0, 0) for Data 1
and X(0) = (µ/m, 0) for Data 2. We note that with these initial approximations we
have mη β = 0.05065...× 10−3 for Data 1 and mη β = 0.1015... × 10−3 for Data 2.
From the result cited in subsection 7.2 the convergence of Newton’s method is assured
and we obtain:
(z∗1 , z∗2 , z∗3 , z∗4) ≈
(
5.0600× 10−8, 5.0600× 10−5, 3.0434× 10−14, 3.0434× 10−11
)
,
for Data 1, while
(z∗1 , z∗2 , z∗3 , z∗4) ≈
(
9.9999× 10−1, 9.9999× 10−3, 9.8702× 103, 9.8702× 10−1
)
,
for Data 2. These values are displayed in columns 3 and 5 of Table 9.3.
In order to compute numerical approximations of w1 and w2 we consider algo-
rithm (8.7) with stepsize h = 1/1000 for Data 1 and Data 2. We use these approxi-
mations in (8.14) and (8.15) to obtain numerical approximations to u(1, t) and v(1, t).
The variables are then dimensionalized using the relations (2.18), (2.19) and (2.20),
and numerical approximations of the concentrations of the complexes, [XY ](t) and
[XFY ](t), and the concentrations of the labelled and unlabelled antigens at x = d,
[X ](d, t) and [XF ](d, t), are then determined. These are displayed in Figures 9.1-9.3
and Figures 9.4-9.6 for Data 1 and Data 2, respectively. In each figure, t denotes the
time in seconds. Table 9.3 displays the numerical approximations of the nondimen-
sional dependent variables at t = 5 for Data 1 and at t = 1 for Data 2. In Table 9.4
we display the results for the dimensionally dependent variables.
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Table 9.3
Nondimensional variables
Variables Data 1 Data 2
t = 5 lim
t→∞
t = 1 lim
t→∞
w1(t) 5.0606 × 10−8 5.0606 × 10−8 9.9990× 10−1 9.9999× 10−1
w2(t) 5.0606 × 10−5 5.0606 × 10−5 1.0156× 10−4 9.9999× 10−3
u(1, t) 3.2503 × 10−14 3.0434× 10−14 9.6556× 103 9.8702× 103
v(1, t) 3.2692 × 10−11 3.0434× 10−11 9.8019× 10−1 9.8702× 10−1
Table 9.4
Dimensional variables
Variables Data 1 Data 2
t = 50seconds lim
t→∞
t = 100seconds lim
t→∞
[XY ](t) 1.6699 × 10−11 1.670 × 10−11 1.5998× 10−6 1.5998 × 10−6
[XF Y ](1, t) 1.6699 × 10−8 1.670 × 10−8 1.6249× 10−10 1.5998 × 10−10
[X](1, t) 5.4280 × 10−17 5.0826 × 10−17 8.0142× 10−1 8.1400 × 10−1
[XF ](1, t) 5.4596 × 10−14 5.0826 × 10−14 8.1356× 10−5 8.1400 × 10−5
From Figures 9.1 (a) and 9.1 (b) we see that both [XY ] and [XFY ] grow monoton-
ically at roughly the same speed to their respective (and rather different) asymptotic
values, which they attain in approximately 30 secs. The two orders of magnitude
difference between [XY ] and [XFY ] would appear to be reflected in the two orders
of magnitude difference between a and aF . Figure 9.2 displays the antigen and the
labelled antigen at the wall (i.e. x = d). One observes that [X ](d, t) drops initially as
a result of the reaction and then grows to a peak due to diffusion (more rapidly than
[XF ](d, t)) before reducing monotonically. The concentration [XF ](d, t) is dissolved
initially from the bound X(b)F . From Figure (9.2)(b) we see that [XF ](d, t) grows to
a peak (considerably smaller than [X ](d, t)) before decreasing monotonically to zero
in about 30 secs. Thus, there is a small time delay while diffusion migrates the XF
molecules to x = d whereupon there is an increase in [XF ](d, t) before the reaction
sets in.
Figures 9.4-9.6 present the corresponding results for the second data set. First
we notice that in this case there is a great deal more of [XY ](t) than [XFY ](t).
Furthermore, since X(b)F must first dissolve to XF before diffusing across (to x = d)
we would expect X to combine with Y first, perhaps with some disassociation to allow
for XF to react with Y so that both could reach equilibrium. At t = 0 the labelled
antigen is ”dumped” at x = 0. The reaction with the antigen takes place rapidly (see
Figure 9.4 (a)) to equilibrium. The labelled antigen diffuses across [0, d] and there
is a period of zero reaction while it does so. When the reaction between XF and
Y takes place there will be few antibody sites available, despite the large value of
k3, and hence the reaction appears slow. We observe that disassociation takes place
(i.e. XY → X + Y ) which although small in Figure 9.4 (a) is actually quite large in
the scale of Figure 9.4 (b). Figure 9.5 (a) shows that [X ](d, t) decreases rapidly due
to a high reaction rate (and no initial competition) before diffusion comes into play
migrating moles of X to x = d. We note that not very much of the X is actually
used up in binding with the Y . This is also true for the XF (c.f. Figure 9.5 (b)).
Both steady states are close to that of the initial concentration. Again this is what
we would expect since there is not a great deal of the antibody on the side wall.
Figures 9.7 (a) and 9.7 (b) compare the results obtained for Data 2 using the nu-
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Fig. 9.1. Numerical approximations of the concentrations of the complexes XY and XFY
obtained with Data 1. (a) Numerical approximation of [XY ](t). (b) Numerical approximation of
[XFY ](t).
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Fig. 9.2. Numerical approximations, for Data 1, of the concentrations of the labelled and unla-
belled antigens at the wall side where the reaction takes place, x = d. (a) Numerical approximation
of [X](d, t). (b) Numerical approximation of [XF ](d, t).
merical approximation of the regular perturbation solutions, w(0)1 (t), w
(0)
2 (t), obtained
from (6.4) and (6.5), and the accurate solutions obtained by the product integration
scheme (8.7) with h = 1/1000. For Data 2 the value of the molar ratio, m = 192.771,
is not very small; however the numerical results obtained in the two different ways
show reasonable agreement.
10. Design considerations and final remarks.
Since the principles of immunoassay were first expounded by Yalow and Berson
[17] in 1959 there has been an exponential growth, not only in the range of applica-
tions to which they have been successfully applied, but also in the number of novel
and ingenious assay designs. This technology has not only been confined to medical
diagnostics, but has also found application in pharmaceutical, veterinary, forensics,
military, food and environment science (see e.g. Wild [16], Shan et al. [15]).
This paper has been concerned with analysing one particular design of a ho-
mogenous immunoassay, the Fluorescence Capillary-Fill Device. A homogeneous im-
munoassay does not require separation of the unbounded tracer (i.e. the labelled
antigen) before the bound signal is measured. The objective of this paper was to
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Fig. 9.3. (a) Comparison between the numerical approximation of 103[X](d, t) (solid line) and
[XF ](d, t) (dashed line) obtained with Data 1. (b) Comparison between the numerical approximation
of 103[XY ](d, t) (solid line) and [XF Y ](t) (dashed line) obtained with Data 1.
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Fig. 9.4. Numerical approximations of the concentrations of the complexes XY and XFY
obtained with Data 2. (a) Numerical approximation of [XY ](t). (b) Numerical approximation of
[XFY ](t).
provide a quantitative and alternative design tool for the bioscientist. Indeed this
model (or, more precisely, a simplified model in a confidential Unilever Research re-
port dealing with the non-competitive case upon which the paper [6] - see also [11]
- was ultimately based) was employed in the development of CLEARBLUE - the
well-known pregnancy testing kit. A code was provided and this tool helped the bio-
scientists appreciate that the device could be made very small (and consequently very
cheaply) and in large batches, suitable for hospital use. Furthermore, simulations
provided an indication of both the plate separation distance and how much antibody
was required to be affixed to the plate surface. In short, this tool obviated a great deal
of experimentation, or at least helped to prioritize experimentation, thus saving time
and allowing Unilever Research, through the company Unimed, to bring the product
to market early.
The device modelled and analyzed in this paper is generic: it is not simply confined
to being used as a pregnancy testing kit. In designing an assay there are a number
of factors that concern bioengineers. Incubation time, or the time to completion
is often important: one wishes the reaction to be completed in finite time and in
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Fig. 9.5. Numerical approximations, for Data 2, of the concentrations of the labelled and unla-
belled antigens at the wall side where the reaction takes place, x = d. (a) Numerical approximation
of [X](d, t). (b) Numerical approximation of [XF ](d, t).
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Fig. 9.6. (a) Comparison between the numerical approximation of [X](d, t) (solid line) and
104[XF ](d, t) (dashed line) obtained with Data 2. (b) Comparison between the numerical approxi-
mation of [XY ](d, t) (solid line) and 104[XFY ](t) (dashed line) obtained with Data 2.
the field, in particular this might be required to be a matter of minutes or even
seconds. It is crucial to know how much antibody and labelled antigen one needs to
affix to the glass plates. The glass plate separation distance also needs to be known
accurately. Finally, precise values for equilibrium constants (sometimes called affinity
constants) are required. These may be deduced from calibration curves or Scatchard
plots (Scatchard [14]).
Incubation times, of course, may be deduced approximately from dimensional ar-
guments. However, they may be obtained quantitatively from the graphs in section 9,
in particular Figures 9.3(b) and 9.6(b). Note that with Data 1 the incubation time
is around 20 seconds while Data 2 (and the lighter conjugate) it is closer to 60 sec-
onds since the completion of both [XY ] and [XFY ] are required for the signal to be
effective. At first glance this might appear counter-intuitive.
Dose-response curves can be useful in assay design. Below (Figures 10.1 and 10.2)
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Fig. 9.7. Comparison between the numerical approximations obtained by the numerical method
(8.7) and the regular perturbation solution obtained from (6.4) and (6.5), for Data 2. (a) Numer-
ical approximation of [XY ](t) obtained by the numerical method (8.7) (large dashed line) and the
regular perturbation solution obtained from (6.4) and (6.5) (small dashed line). (b) Numerical ap-
proximation of [XFY ](t) obtained by the numerical method (8.7) (large dashed line) and the regular
perturbation solution obtained from (6.4) and (6.5) (small dashed line).
are displayed graphs of the percentage bound to free antigen:
[XY ]/[X ]
1 + [XY ]/[X ] × 100%,
where [X ], [XY ] are understood to be the appropriate concentrations at completion
(i.e. concentrations as t → ∞) plotted against the total antigen concentration (i.e.
[X ](0) = a). These may be efficiently achieved using the asymptotic results of sec-
tion 7, in particular, the dimensional form of (7.24). We note that increasing the
concentration of the antibody shifts the percentage bound curve to the right, towards
higher concentrations of antigen.
In Figures 10.3 and 10.4 we observe that increasing the antibody equilibrium
constant Keq =
k1
k2
acts to increase the slope of the response. Similar results may be
obtained for KFeq =
k3
k4
.
Another useful tool employed by the bioscientists is the Scatchard plot. We have
Keq =
[XY ]
[X ](c− [XY ]− [XFY ])
,(10.1)
where [X ], [XY ] and [XFY ] are again to be interpreted as the completion concentra-
tions. Thus rearranging (10.1) we have
y = −Keqx+Keq(c− [XFY ]),
where y = [XY ]/[X ] and x = [XY ]. Once again we may plot the ratio of bound
antigen to free antigen (y) against the bound antigen (x) to produce the plot in Figures
10.5 and 10.6. The slope of the line then provides an estimate of the equilibrium
constant. In this case we have Keq ≈ 7.9 × 108 for Data 1 and Keq ≈ 9.7 × 109 for
Data 2.
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Fig. 10.1. Graph of the percentage bound to free unlabelled antigen, X, for Data 1 and for
several values of the antibody.
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Fig. 10.2. Graph of the percentage bound to free unlabelled antigen, X, for Data 2 and for
several values of the antibody.
A similar Scatchard plot may be obtained for the labelled equilibrium constant
KFeq = k3/k4.
To conclude, this paper has been principally involved with the development of a
model to describe antibody/antigen reactions occurring in the Fluorescence Capillary-
Fill Device as described and designed by Badley et al.[1]. The mathematical model
was non-dimensionalised, and then re-characterized both as a system of two Volterra
integro-differential equations and as a system of four Volterra integral equations.
These re-characterizations have allowed us to obtain partial existence and unique-
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Fig. 10.3. Graphs of the percentage bound to free unlabelled antigen, X, for Data 1 and for
several values of the antibody equilibrium constant Keq = k1/k2.
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Fig. 10.4. Graphs of the percentage bound to free unlabelled antigen, X, for Data 2 and for
several values of the antibody equilibrium constant Keq = k1/k2.
ness results (thereby verifying the correctness of the model), a regular perturbation
solution and asymptotic results for small and large t. Numerical methods were briefly
discussed and results from real data have been given for human immunoglobulin G.
The paper concluded by discussing how some of these mathematical tools may be
employed to rapidly produce an optimal design, or at least aid in prioritizing the
bioscientist’s experimentation, by providing good estimates of the parameters that
characterize the system.
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